Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 137,225 | 103,246 | 73,036 | 36,138 | 58,275 |
| Receivables | 117,981 | 123,946 | 131,557 | 144,293 | 150,260 |
| Inventories | 34,317 | 36,858 | 32,976 | 34,838 | 32,259 |
| TOTAL | $308,282 | $288,540 | $258,361 | $235,645 | $263,431 |
| Non-Current Assets | |||||
| PPE Net | 97,966 | 100,289 | 100,582 | 103,463 | 99,798 |
| Intangibles | 155,237 | 155,380 | 155,507 | 155,592 | 155,696 |
| Other Non-Current Assets | 29,314 | 31,665 | 28,836 | 26,835 | 46,805 |
| TOTAL | $282,517 | $287,334 | $284,925 | $285,890 | $302,299 |
| Total Assets | $590,799 | $575,874 | $543,286 | $521,535 | $565,730 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 223 |
| Accounts payable and accrued liabilities | 27,981 | 26,840 | 27,218 | 41,588 | 39,113 |
| Accrued Expenses | 25,174 | 21,957 | 25,443 | 28,637 | 27,972 |
| TOTAL | $85,614 | $84,856 | $86,647 | $95,690 | $94,375 |
| Non-Current Liabilities | |||||
| Long Term Debt | 205,377 | 201,709 | 198,106 | 194,568 | 300,000 |
| Deferred Revenues | 6,615 | 7,573 | 8,025 | 7,932 | 8,325 |
| Other Non-Current Liabilities | 49,622 | 52,226 | 49,555 | 42,933 | 46,045 |
| TOTAL | $255,126 | $254,092 | $247,708 | $237,560 | $346,148 |
| Total Liabilities | $340,740 | $338,948 | $334,355 | $333,250 | $440,523 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,962 | 45,929 | 45,894 | 45,846 | 46,089 |
| Common Shares | 1,430 | 1,430 | 1,430 | 1,430 | 1,430 |
| Retained earnings | 448,136 | 436,668 | 409,156 | 382,266 | 367,471 |
| Other shareholders' equity | -2,641 | -3,045 | -3,115 | -2,430 | -155 |
| TOTAL | $250,059 | $236,926 | $208,931 | $188,285 | $125,207 |
| Total Liabilities And Equity | $590,799 | $575,874 | $543,286 | $521,535 | $565,730 |